| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |